Publications by authors named "S Prey"

Claim this Profile
B
Brief Communication: Severe Immuno-Induced Rhinosinusitis With Deafness After Ipilimumab and Nivolumab Combination for Melanoma, and Review of the Literature.
Maëva Boyer, Mélodie Kerimian, Alix Ribadeau Dumas, Skander Korbi, Caroline Dutriaux, Sorilla Prey

J Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.
Iván Márquez-Rodas, Caroline Dutriaux, Philippe Saiag, Luis de la Cruz Merino, Eduardo Castañón Álvarez, Sorilla Prey

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.
Iván Márquez-Rodas, Caroline Dutriaux, Philippe Saiag, Luis de la Cruz Merino, Eduardo Castañón Álvarez, Sorilla Prey

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotics use decreases survival in cutaneous squamous cell carcinoma patients receiving immune checkpoint inhibitors.
C Bonnefin, S Schneider, E Gérard, C Dutriaux, T Ferte, S Prey

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational study.
Alexandra Ladouceur, Thomas Barnetche, Sorilla Prey, Caroline Dutriaux, Émilie Gerard

Joint Bone Spine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis